Capstone Holding Corp. (CAPS)

OTCMKTS · Delayed Price · Currency is USD
37.00
0.00 (0.00%)
Aug 15, 2022, 9:10 AM EST
611.54%
Market Cap 353.05K
Revenue (ttm) 48.35M
Net Income (ttm) -5.74M
Shares Out 157.61K
EPS (ttm) -36.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Open 37.00
Previous Close 37.00
Day's Range 37.00 - 37.00
52-Week Range 6.10 - 37.50
Beta -0.75
Analysts n/a
Price Target n/a
Earnings Date Apr 2, 2025

About Capstone Holding

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone cladding products, natural stone landscape products and related goods for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. opera... [Read more]

Sector Materials
Founded 1987
Employees 47
Stock Exchange OTCMKTS
Ticker Symbol CAPS
Full Company Profile

Financial Performance

In 2023, Capstone Holding's revenue was $48.35 million, a decrease of -21.45% compared to the previous year's $61.56 million. Losses were -$5.74 million, 57250.0% more than in 2022.

Financial Statements

News

Capstone Holding Corp. Announces CEO Change

ALSIP, IL / ACCESSWIRE / December 9, 2024 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective December 2, 2024, Michael Toporek resigned in good standing as CEO of the Company and will con...

17 days ago - Accesswire

Capstone Holding Corp. Reinstates Tax Benefit Plan

ALSIP, IL / ACCESSWIRE / May 3, 2024 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") On May 1, 2024, the Board of Directors (the "Board") of Capstone Holding Corp. (the "Company") authorized and...

8 months ago - Accesswire

Capstone Holding Corp. Announces Change in Board of Directors

ALSIP, IL / ACCESSWIRE / December 29, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective December 28, 2023, the Company accepted the resignations of Frederic R. Feldman, PhD, and Elw...

1 year ago - Accesswire

Capstone Holding Corp. Announces Change of Equity Ownership in Diamond Products Holding, LLC

ALSIP, IL / ACCESSWIRE / November 21, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective November 16, 2023, the Company reached agreement to revise its accounting treatment for Capst...

1 year ago - Accesswire

Capstone Holding Corp. Announces CFO Change

ALSIP, IL / ACCESSWIRE / August 28, 2023 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") Effective August 25, 2023, Omar Rabbani resigned in good standing as Chief Financial Officer of the Compa...

1 year ago - Accesswire

Capstone Therapeutics Corp. Announces Results Of Annual Meeting

ALSIP, IL / ACCESSWIRE / March 6, 2023 / Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company") The Annual Meeting of Stockholders of Capstone Therapeutics Corp., a Delaware corporation, was held on...

1 year ago - Accesswire

Capstone Therapeutics Corp. Announces Results of Annual Meeting

ALSIP, IL / ACCESSWIRE / March 7, 2023 / Capstone Therapeutics Corp. (OTCQB: CAPS) ("the Company") The Annual Meeting of Stockholders of Capstone Therapeutics Corp., a Delaware corporation, was held o...

1 year ago - Accesswire

Capstone Holding Corp. Announces Exercise Of Secured Debt And Interest Conversion Option By Majority Shareholder, BP Peptides, LLC

ALSIP, IL / ACCESSWIRE / June 21, 2022 / Capstone Holding Corp. (OTCQB:CAPS) ("the Company") EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 78,333 SHARES OF THE COMPANY'S COMMON ...

2 years ago - Accesswire

Capstone Therapeutics Corp. Announces Name Change to Capstone Holding Corp.

ALSIP, IL / ACCESSWIRE / February 25, 2022 / Capstone Therapeutics Corp. (OTCQB:CAPS) ("the Company"), The Company is please to announce a name change effective on this date to Capstone Holding Corp. ...

3 years ago - Accesswire

Capstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC and Change in Control

ALSIP, IL / ACCESSWIRE / December 28, 2020 / Capstone Therapeutics (OTCQB:CAPS) ("the Company"): EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION; ISSUANCE OF 24,900 SHARES OF THE COMPANY'S COM...

4 years ago - Accesswire